ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GLPG Galapagos

416.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Galapagos GLPG London Ordinary Share
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 416.00 01:00:00
Open Price Low Price High Price Close Price Previous Close
416.00
more quote information »

Galapagos GLPG Dividends History

No dividends issued between 20 Jun 2014 and 20 Jun 2024

Top Dividend Posts

Top Posts
Posted at 04/3/2011 06:46 by jammytass
glpg > has made large profits and will be one of the worlds leading cmpy traded on euronext, wish they would come back to uk market!!!!
Posted at 20/9/2006 09:56 by jonwig
Mechelen, Belgium; 19 September 2006 - Galapagos NV (Euronext & LSE:
GLPG) has placed 1,305,074 new shares in a successful private
placement with Fortis Bank NV, at a price of Eur8.50 per share. Fortis
intends to place these new shares with international institutional
clients via an accelerated bookbuilding procedure. Galapagos raised
gross proceeds of Eur11.1 million.
The Board of Directors of Galapagos has authorized this capital
increase of ยค11.1 million by the issuance of 1,305,074 new ordinary
shares, effective as of 19 September 2006, at a price per share of
Eur8.50, reflecting the average share price on Euronext Amsterdam over
the last 30 days. The new shares are expected to be admitted to
trading and listing on Eurolist by Euronext Brussels and Euronext
Amsterdam and on AiM on 22 September 2006. As a result of the
placement, Galapagos will have 14,355,817 ordinary shares
outstanding.
Posted at 06/9/2006 07:50 by jonwig
Collaboration of BioFocus with a US research unit, revenue of $3m over 2.5 years for GLPG.